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Euphemia C. A. M. Houdijk6, Marjolein Luman7, Roos Nuboer8, Jaap Oosterlaan7, Per Winterdijk4
and Frank J. Snoek1,2,9Abstract
Background: Strict glycemic control during adolescence decreases the risk of developing complications later in life,
even if this level of control is not maintained afterwards. However, the majority of adolescents with type 1 diabetes
(T1D) are in poor control and so far medical or psychological interventions have shown limited success.
Adolescence is characterized by major biological, psychosocial, cognitive and parent–child relationship changes and
the complex interaction between these developmental trajectories, and its impact on health outcomes is still poorly
understood. A specific topic of interest in this context is the timing of diagnosis. The longitudinal study DINO
(Diabetes IN develOpment) aims to examine:
1) If and how the onset of T1D before vs. during puberty results in different outcomes of glycemic control,
self-management, psychological functioning and diabetes-related quality of life.
2) The timing of onset of disturbed eating behavior, its risk factors and its prospective course in relation to
glycemic and psychological consequences.
3) If and how the onset of T1D before vs. during puberty results in different family functioning and parental
well-being.
4) If and how the cognitive development of youth with T1D relates to glycemic control and diabetes
self-management.
Methods/design: DINO, a longitudinal multi-center cohort study is conducted in youth with T1D in the age range
8–15 years at baseline. Participants will be divided into two subgroups: pre-pubertal and pubertal. Both groups will
be followed for 3 years with assessments based on a bio-psychosocial model of diabetes, scheduled at baseline,
12 months, 24 months and 36 months examining the biological, psychosocial -including disturbed eating behaviors- and
cognitive development, family functioning and parental well-being.
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Discussion: A better understanding of how the different trajectories affect one another will help to gain insight in the
protective and risk factors for glycemic outcomes and in who needs which support at what moment in time. First results
are expected in 2016.
Keywords: Type 1 diabetes, Development, Youth, Quality of life, Well-being, Adolescence, Cognition, HbA1c, Psychosocial,
ParentsBackground
In 2009, a report in the Lancet concluded that: “If
present trends continue, doubling of new cases of type 1
diabetes in European children younger than 5 years is
predicted between 2005 and 2020, and prevalent cases
younger than 15 years will rise by 70 %. Adequate
health-care resources to meet these children’s needs
should be made available” [1]. This clearly underscores
the importance of understanding the specific (changing)
needs of youth with type 1 diabetes (T1D) to improve
quality and efficacy of pediatric diabetes care. This holds
in particular for adolescent diabetes care, as clinical data
have shown repeatedly that during adolescent years
patients have great difficulty reaching and maintaining
optimal glycemic control [2, 3]. Less than 15 % of the
young patients keep constant or reach HbA1c levels
below 8 % (64 mmol/mol) from pre-puberty to young
adulthood [2, 4]. In contrast to earlier belief, puberty
years provide no protection against the risk of develop-
ing microvascular complications in later years as a result
of prolonged hyperglycemia. In fact the reverse is true:
Diabetes Control and Complications Trial/Epidemiology
of Diabetes Interventions and Complications (DCCT/
EDIC) Study has convincingly shown that the better the
glycemic control during adolescence, the lower the riskFig. 1 A framework for understanding the development and outcomes from
and Sherpa [74]of developing complications later on in life - even if that
level of control is not maintained afterwards [5]. Adoles-
cence is a critical period for the establishment of lifelong
positive and risky health-related behaviors and, import-
antly, such ‘programming’ apparently applies to mental
health as well [6]. In what manner biological, psycho-
social and cognitive programming interact in youth with
T1D is largely unknown. Of interest is the question how
different trajectories develop during pre- and pubertal
years, and to what extent these years offer a window of
opportunity for early detection and targeted interven-
tions to improve health outcomes. With the longitudinal
cohort research DINO (Diabetes IN develOpment) the
complex interaction of biological, psychosocial and cog-
nitive development, family functioning and parental
well-being will be studied. In order to do so, a bio-
psychosocial approach is called for. The bio-psychosocial
model appreciates these complex interactions, the onset
and the demands of diabetes (Fig. 1).Biological development
There is substantial variation between individuals in the
time of onset, duration and termination of the pubertal
development and these differences have social and psy-
chological consequences [7]. In addition is known thatpre-puberty into puberty. Bio-psychosocial model based on Holmbeck
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with diabetes compared to healthy youth [8, 9]. However,
the consequences for diabetes self-management and
health outcomes have not been studied. Research revealed
that glycemic control tends to be better for children with
shorter diabetes duration [10–12]. One study specifically
showed that in T1D patients with pubertal compared to
pre-pubertal onset, glycemic control was better and daily
insulin doses were lower after 6 years of diabetes, irre-
spective of age-related factors [13]. Perhaps as a result of
that, pre-pubertal onset of diabetes is found to predict
earlier onset of retinopathy [14], suggesting that youth di-
agnosed during or after puberty do better than those diag-
nosed early in life. Older longitudinal studies showed that
patients diagnosed before the age of 13 had better adher-
ence to diabetes management over a 4 year follow-up
period compared to patients diagnosed after this age [15].
Deterioration in adherence occurred in all age ranges as
duration increased [10]. It is of note, that these longitu-
dinal studies used age as an indicator for pubertal status
and not the actual physical development such as Tanner
stage, in which the based on primary and secondary sex
characteristics is scaled [16]. Gender differences and indi-
vidual variations in puberty onset were therefore not taken
into account in these previous studies. Reviews have
clearly identified the lack of prospective cohort studies in
representative (pre)pubertal groups [17, 18]. Whether de-
veloping diabetes during puberty alters the duration and
termination of puberty and results in psychological risks is
unknown.
Psychosocial development
In general, mid-adolescence appears the most vulnerable
period for developing psychological problems [19]. In
youth with diabetes, rates of depression, anxiety and dis-
turbed eating behavior tend to be worrisomely elevated
and are associated with poor glycemic control [20–23]. Ad-
olescents with T1D have more emotional issues compared
to healthy peers [24]. A study in female adolescents with
diabetes showed that adolescents diagnosed <3 years from
menarche [25], a lower overall sense of control was associ-
ated with poorer metabolic control. Hormonal fluctuations
due to puberty can result in frequent ‘unexplainable’ (high)
blood glucose values, easily inducing feelings of anger, frus-
tration and discouragement, thereby contributing to poor
adherence and subsequent deterioration of glycemic con-
trol and quality of life (QoL) [26]. Ten years after diagnosis,
young adults with diabetes seem in general to be psycho-
logically well adjusted, but do report lower perceived com-
petence, including self-worth [27]. Low (diabetes specific)
self-esteem is found to be associated with poor adherence
and a predictor of deteriorating glycemic control in late
adolescence [4, 28]. However, as stated before, the majority
of these studies have not made a distinction between pre-and pubertal onset of diabetes and can therefore not inform
us on the relevance of timing of diabetes onset on psycho-
social development.
Adolescents with T1D are at an increased risk of dis-
turbed eating behavior (DEB) compared to healthy peers
[29–33] due to hormonal changes [3], the focus on food,
issues around control and autonomy in diabetes care.
This ‘Diabulimia’ has been frequently reported among
adolescents with T1D; 33–53 % reported to engage in
unhealthy eating behaviors and insulin restriction for
weight purposes was prevalent in up to 30 % of patients
[31, 34–39]. DEB increases the risk for poorer glycemic
control, earlier complications from diabetes, particu-
larly retinopathy and nephropathy as well as mortality
[32–37, 40–43]. In T1D, it is suggested that in most
cases the DEB developed after diabetes onset [44]. Al-
though the peak of onset of DEB is in adolescence only
one study assessed risk factors for the onset of DEB in
adolescent girls [45]. Currently, diabetes teams are hesi-
tant to discuss DEB with their patients [46], because they
are afraid they might bring the association between insulin
and weight control to mind of the adolescent. It is import-
ant to know the timing of onset of DEB, who is at risk,
how to address these behaviors and to be able to identify
those at risk for DEB [40].
Cognitive development
Neuropsychological research shows that children with
T1D, especially those with early-onset diabetes (≤6 years
of age), have mild impairment of cognitive functioning
[47] including poorer academic achievement [48], lower
verbal intelligence, and worse performance on measures
of attention, executive function, mental flexibility, and
psychomotor speed [47] compared to healthy controls.
This challenges adolescents’ diabetes adherence behav-
iors, since these tasks are of great importance to
organize and plan the diabetes management.
In general, adolescence is a critical period for brain
maturation, essential for the development of higher cog-
nitive functions. Significant improvements in cognitive
processing speed and intellectual functioning are evident
throughout adolescence and mature in young adulthood,
with the most dramatic improvements occurring in the
development of executive functions including abstract
thought, organization, decision making, planning, and
response inhibition [19, 49]. This implies that later on in
adolescence the ability to critically outweigh the costs
and benefits of (non) adherence behaviors increases [50].
However, until that time the adolescent’s brain is in-
clined to engage in risk taking behavior and prefers im-
mediate rather than long term satisfaction [49]. Given
their stage of cognitive development and the challenges
facing adolescents might challenge their ability to man-
age their diabetes on a daily basis.
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The way the family of T1D youth functions is important,
both as determinant and consequent of poor diabetes
control. A negotiating parent–child environment is
beneficial for children with diabetes. In addition, shared
responsibility for diabetes management tasks is shown to
be associated with better psychological health, self-care
behavior and metabolic control [51–53]. A lack of col-
laboration between children and parents can result in
conflicts which are often associated with poor glycemic
control and QoL [54, 55], however, this seems to be re-
lated to ethnicity [56]. Shared responsibility regarding
diabetes tasks between parents and adolescents (rather
than complete/sudden transfer of parental control) for
diabetes management may serve as a way to achieve au-
tonomy for self-care. Youth with an inordinate self-care
autonomy relative to their psychological maturity are at
greater risk of poor treatment adherence, worse diabetic
control and more hospitalizations [57]. Inconsistencies
regarding competence and independence between par-
ents and children with T1D is associated with poorer
diabetes outcomes [58]. Furthermore, the better parents
are able to adopt youth’s perspectives the better the gly-
cemic control [59]. Recent research reveals that parental
involvement [60] in diabetes care and greater overall
parental support [61] are associated with better health
[60] and service use [61], and greater parental motiv-
ation is related to child’s healthier diet [62]. These find-
ings highlight the importance of parenting practices.
One of the major tasks for parents is to be responsive to
adolescents’ needs for increasing responsibility and deci-
sion making power while at the same time maintaining a
high level of cohesiveness in the family. However, paren-
tal well-being influences the way this task proceeds. Re-
cent research reveals that parents with T1D children
were more anxious and perceived less family cohesion
than the parents of healthy youth [63]. The diagnosis,
hypoglycemic events, as well as the chronic nature of
diabetes and its demands all contribute to anxiety and
depressive symptoms in parents [64, 65]. Importantly,
worse parental well-being is shown to be associated with
poorer glycemic control of the children [66, 67] and ma-
ternal depression is found to be associated with acute
hospitalization [68]. Of interest is how family function-
ing and parental well-being influences adolescents’ dia-
betes outcomes and development, and how parental
well-being influences youths’ diabetes and psychosocial
outcomes.
Overall, studies integrating the biological, psychosocial
and cognitive developmental trajectories, family func-
tioning and parental well-being are lacking [18] with a
few positive exceptions. Wiebe et al. examined the rela-
tionship between self-efficacy, parental responsibilities,
pubertal maturation and adherence [69]. Luyckx et al.determined developmental classes of glycemic control in
young people with T1D throughout adolescence and
emerging adulthood, in relation to general family climate
and self-concept [4]. King et al. used latent growth class
analysis to look at trajectories of metabolic control in re-
lation to autonomy, diabetes management and hospi-
talizations [60]. These studies used a person-centered
approach that is uniquely suited to capture diversifica-
tion in glycemic control, looking for meaningful sub-
groups characterized by unique developmental pathways.Overall aims and research question
There is paucity of evidence with regard to the question
if and how (living with) diabetes during pre-pubertal
years and early adolescence predict glycemic control,
self-management, psychosocial functioning and diabetes-
related QoL during later years. The importance of being
diagnosed with diabetes before versus during puberty
has hardly received attention in past decades, while the
mechanisms and role of puberty could give important
information for (well-timed) future interventions.
The primary goal of DINO is to further our under-
standing how the onset of diabetes impacts the bio-
logical, psychosocial and cognitive development and
family functioning and parental well-being during pre-
pubertal and pubertal years in Dutch youth with T1D.
With DINO we will examine:
1) If and how the onset of T1D before vs. during
puberty results in different outcomes of glycemic
control, self-management, psychological functioning
and diabetes-related quality of life.
2) The timing of onset of disturbed eating behavior, its
risk factors and its prospective course in relation to
glycemic and psychological consequences.
3) If and how the onset of T1D before vs. during
puberty results in different family functioning and
parental well-being.
4) If and how the cognitive development of youth with
T1D relates to glycemic control and diabetes
self-management.Methods/Design
A prospective multi-center cohort study will be con-
ducted in youth with T1D in the age range 8–15 years at
baseline. For 3 years, participants’ biological, psycho-
social and cognitive development will annually be
assessed (at baseline, 12 months, 24 months and
36 months), as represented in Fig. 2. During the course
of the study, newly diagnosed youth will be included
6 months after diagnosis -when diabetes regimen is
habituated- and follow the scheduled assessments. By
consequence, not all newly diagnosed will have the same
Fig. 2 Flowchart annual DINO procedure
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two subgroups:
A) Pre-Pubertal Onset of Diabetes (Tanner stage 1) and
B) Pubertal Onset of Diabetes (Tanner stage 2–5).
Group A will provide information on the effects of pu-
berty on the developmental trajectories in relation to
diabetes outcomes in youth already diagnosed with dia-
betes. Group B will provide information on how the on-
set of diabetes affects the developmental trajectories.
Procedure and participants
Five Dutch pediatric diabetes care clinics agreed to par-
ticipate. Pediatricians will recruit youth diagnosed with
T1D and their parents. Exclusion criteria are: other types
of diabetes than Type 1 (e.g. type 2 or MODY), younger
than 8 years or older than 15 years at baseline, not
speaking the Dutch language, and mental retardation.
All medical parameters are taken from hospital charts
and no extra tests will be performed. As represented in
Fig. 2, youth between 8 and 15 years at baseline with
T1D who consent to participate will complete an online
survey regarding their psychosocial development. If a
paper survey is preferred or participants do not respond
to the e-mail, a paper version is sent to their home ad-
dress. Due to the age difference, 8–11 year olds will
complete a shorter and more simple survey than partici-
pants 11 years and older. To gain better insight in the
perspectives of the adolescents about DEB, we will con-
duct interviews with a selection of youth. Only youth at
risk (based on their answers on the online survey) will
be invited for the interview. The interviews will take
place at the adolescent’s residence or at the outpatientclinic, depending on the adolescent’s preference. Parents
will report on family functioning and parental well-being
by an online survey as well, unless the paper version is
preferred. A neuropsychological test battery will be used
to assess the cognitive development. Most test results
will be compared to normative data, however, three
measures will also be administered to a gender and age
matched sample of 100 healthy controls as reference
values are not yet available for these tasks. These healthy
controls are derived from schools in the Netherlands
and will be measured cross-sectional.
Ethical considerations
The study protocol was approved by the medical ethical
committee of VU University Medical Centre (date:
December 19th, 2012). Youth and parents are provided
with written information about the study and are asked
to provide written informed consent (both parents -if
applicable- and youth ≥12) prior to the data collection.
Study measures
An overview of study measures is shown in Tables 1, 2
and 3.
A full description of these measures is presented in
the online text Additional file 1.
Data analyses
Using descriptive statistics, baseline data are analyzed
cross-sectionally and scores are compared with reference
values when applicable. Uni-variate analysis ANOVA will
be used to explore differences between boys and girls
and Tanner stages. Pearson or Spearman correlation is
used to explore associations between several outcomes
(such as age, cognitive development, social-emotional
Table 1 Overview of study measures – Socio-Demographic and clinical data
History Baseline 12 months 24 months 36 months
Socio-Demographic data
Date of birth H
Gender H
Ethnicity P
Education level child P + C P + C P + C P + C
Socioeconomic status P
Family structure C C C C
Family related life events P P P P P
Clinical data
History of medical and psychological co-morbidity H H H H H
Treatment regime H H H H
Care consumption H H H H H
Tanner stage at time of diagnosis [16] H
Current Tanner stage [16] H H H H
Blood pressure H H H H
Weight and Height H H H H
Hemoglobin A1c (HbA1c) H H H H H
Number of diabetes related hospitalizations H H H H H
DKA H H H H H
Indicators for complications H H H H H
Severe hypoglycemic episodes P P P P P
H Hospital, P Parent, C Child, HC Healthy control
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ing, QoL, diabetes management and DEB). To examine
whether associations are mediated by other variables,
multiple mediation analysis will be used [70].
With regard to the cognitive development, perform-
ance on the computerized measures will be administered
to a gender and age matched sample of 100 healthy con-
trols. Because of the longitudinal nature of this study,
Generalized Estimation Equations (GEE) is used to
examine the differences between the two groups diagno-
sis pre-puberty vs puberty on glycemic control, self-
management, psychological functioning and diabetes
related QoL. The differences between the two groups on
family functioning and parental well-being and the de-
velopment of DEB are investigated by GEE as well. GEE
adjusts for the correlation between repeated observa-
tions taken in the same patient and has the advantage of
handling longitudinal data on subjects with varying
numbers of unequally spaced observations. The latter is
important, because the assessments are scheduled within
routine care and as a consequence, the time between the
consultations will differ. Longitudinal linear regression
analyses, using GEE, enables us to examine the associ-
ation between the developmental trajectories in relation
to diabetes onset and outcomes.Data are controlled for demographic and clinical vari-
ables and examined for associations with and predictors
of biological and social-emotional developmental out-
comes. Latent class growth analysis is used to identify
developmental trajectories of glycemic control and psy-
chological, cognitive and family functioning.
For the analyses of the interviews, a framework ap-
proach is used [71, 72]: interviews are transcribed verba-
tim and key words and codes extract content from the
text is assigned by two researchers, at least for the first
few transcripts using Atlas.Ti.
Sample size
Sample size calculations indicate that a sample of 86 pa-
tients is sufficient to detect a statistically clinically differ-
ence of ≥ 0.5 % HbA1c (sd = 1.1 %) at a significance level of
5 % with a power of 80 %, given three follow-up measure-
ments using GEE analyses and taking into account the
within-subject correlation (rho = 0.7). Sample size calcula-
tions for psychological functioning (as measured with the
SDQ) indicate that a sample of 40 patients is sufficient to
detect a difference of 20 % in the proportion likely
“cases” with mental health disorders (assuming p = 0.33
[73]) at a significance level of 5 % with a power of 80 %,
given three follow-up measurements using longitudinal
Table 2 Overview of study measures – Psychosocial development, DEB, Cognitive development
Psychosocial development
Strengths and Difficulties Questionnaire (SDQ) [75] P + C ≥11 P + C ≥11 P + C ≥11 P + C ≥11
Revised Children’s Quality of Life Questionnaire (KINDL-R) self esteem subscale [76] C C C C
KIDSCREEN Autonomy subscale [77, 78] C ≥11 C ≥11 C ≥11 C ≥11
Diabetes Family Responsibility Questionnaire (DFRQ) [79] P + C ≥11 P + C ≥11 P + C ≥11 P + C ≥11
MIND Youth Questionnaire (MY-Q) [80] C C C C
Adapted version for 8–10 year olds
Confidence in Diabetes Self-care Youth (CIDS-youth) [81] C ≥11 C ≥11 C ≥11 C ≥11
Mismanagement scale – renewed [82] C ≥11 C ≥11 C ≥11 C ≥11
Adherence H H H H H
Disturbed Eating Behavior (DEB)a
2 questions regarding dieting status and frequency C ≥11 C ≥11 C ≥11
Diabetes Eating Problems Scale-Revised (DESP-R) [36, 43] C ≥11 C ≥11 C ≥11
Questions of the AHEAD study [35] C ≥11 C ≥11 C ≥11
DEB semi structured interview C ≥11
2 MY-Q subscale body and weight [80] P P P
Cognitive development
Wechsler Intelligence Scale for Children III (WISC-III) subtests Information;
Picture Arrangement; Arithmetic; Block Design; Digit Span [83, 84]
C + HC C C C
Attention Network Task (ANT)-adapted version [85, 86] C + HC C C C
Eriksen Flanker Task [87, 88] C + HC C C C
Klingberg Task – adapted version [86, 89, 90] C + HC C C C
Behavior Rating Inventory of Executive Functioning questionnaire (BRIEF) [91, 92] C + HC P P P
H Hospital, P Parent, C Child, HC Healthy control
aDEB is assessed in a step-wise manner in order to minimize the burden in adolescents with no DEB and younger participants. Kindly note the online text
Additional file 1
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within-subject correlation (rho = 0.2). This means that
in order to detect differences in HbA1c and likely cases
of psychological dysfunction between youth with pre vs.
pubertal onset of diabetes, both groups should contain
at least 43 patients. Given an expected drop-out rate of
10 %, we will include at least an additional 4 patients in
each group. Therefore, we aim to include a minimum of
100 boys and 100 girls (N = 200).
Discussion
To the best of our knowledge, only a few studies have
examined the effect of diabetes onset during pubertal vs.
pre-pubertal years and little longitudinal research is
available in children and teenagers with T1D, although aTable 3 Overview of study measures – parental assessment
Parental assessment
Problem Areas In Diabetes-Parents Revised (PAID-PR) [93, 94] P P P P
WHO-Five Well-being Index (WHO-5) [95–97] P P P P
Diabetes Family Behavior Checklist (DFBC) [98] P P P P
H Hospital, P Parent, C Child, HC Healthy controllot changes during pubertal years. There is large individ-
ual variability in glycemic and psychological trajectories.
The way youth and families cope with puberty and the
developmental changes differ as well. In our research
project DINO we aim to assess the different develop-
mental trajectories (biological, psychosocial -including
disturbed eating behaviors- and cognitive) and family
functioning and parental well-being. This will provide
insight in protective and risk factors for glycemic out-
comes and in who needs which support at what mo-
ment in time. Better understanding contributes to the
optimization of pediatric diabetes care. This might in-
clude the use of more sensitive screening instruments,
for example to assess cognitive functioning in relation
to self-management, risk factors for DEB and other
psychological problems. This would enable diabetes
teams to better personalize their care for adolescents
with diabetes. Better understanding can contribute to
the development of new interventions aimed at, for ex-
ample, prevention and/or treatment of depressive symp-
toms and better tailoring of self-management education to
the developmental phase of the child. First results of
DINO are expected in 2016.
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A selection bias and the adolescents lost to follow up
might influence the external validity of the results. How-
ever, this is almost unavoidable in longitudinal research
studies. In addition, the newly diagnosed youth are not
followed the entire 3 years of the study. To assess psy-
chological development and family functioning and par-
ental well-being self-report measures are used. With
regard to the cognitive development, there can be an in-
terviewers or observers bias as multiple test leaders will
perform the neuropsychological assessments throughout
the Netherlands. With a standardized training program
we try to minimize the bias. The use of neuroimaging
techniques such as functional Magnetic Resonance Im-
aging (fMRI) might provide a more objective, additional
source of information, nonetheless this was not an op-
tion within the current budget. As seen in the bio-
psychosocial model (Fig. 1) the T1D adolescent func-
tions in a broad social network. School and friends for
example play an important role in youth’s development,
yet we did not include these factors because of the feasi-
bility of the study.
Additional file
Additional file 1: Study measures online text supplement.
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